Pharsight

Drizalma Sprinkle patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10959982 SUN PHARM Duloxetine sprinkles
Apr, 2037

(13 years from now)

US10413525 SUN PHARM Duloxetine sprinkles
Apr, 2037

(13 years from now)

US9839626 SUN PHARM Duloxetine sprinkles
Apr, 2037

(13 years from now)

US11202772 SUN PHARM Duloxetine sprinkles
Apr, 2037

(13 years from now)

Drizalma Sprinkle is owned by Sun Pharm.

Drizalma Sprinkle contains Duloxetine Hydrochloride.

Drizalma Sprinkle has a total of 4 drug patents out of which 0 drug patents have expired.

Drizalma Sprinkle was authorised for market use on 19 July, 2019.

Drizalma Sprinkle is available in capsule, delayed rel pellets;oral dosage forms.

The generics of Drizalma Sprinkle are possible to be released after 13 April, 2037.

Drugs and Companies using DULOXETINE HYDROCHLORIDE ingredient

Market Authorisation Date: 19 July, 2019

Treatment: NA

Dosage: CAPSULE, DELAYED REL PELLETS;ORAL

More Information on Dosage

DRIZALMA SPRINKLE family patents

Family Patents